As of 2024-12-11, the EV/EBITDA ratio of Vifor Pharma AG (VIFN.SW) is
15.37.
EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. VIFN.SW's latest enterprise value
is 10,391.69 mil CHF. VIFN.SW's TTM EBITDA according to its financial statements is
676.10 mil CHF. Dividing these 2
quantities gives us the above VIFN.SW EV/EBITDA ratio.
|
Range |
Selected |
| Trailing P/E multiples |
7.3x - 13.2x |
10.2x |
| Forward P/E multiples |
11.2x - 15.2x |
13.0x |
| Fair Price |
82.49 - 143.75 |
117.42 |
| Upside |
-50.4% - -13.5% |
-29.3% |